Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New Merck compounds selectively antagonize alpha1A-adrenoceptors

June 29, 2000

Compounds with urethra-selective contractile activity in development for urinary incontinence

June 28, 2000

Celsion submits IND for phase II trials of BPH treatment

June 28, 2000

New compounds described by Dong-A for male erectile dysfunction

June 27, 2000

(S)-Oxybutynin phase II trial successfully completed

June 26, 2000

Agents for use in BPH in development at Merck & Co.

June 23, 2000

Safety of oral sildenafil demonstrated in men with heart disease

June 22, 2000

Binding and functional profile of KMD-3213 predicts low propensity for vascular side effects

June 21, 2000

Once-daily Ditropan XL gains marketing approval in U.K.

June 21, 2000

Vivus signs international marketing agreement for Muse and Alibra

June 21, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...